GJ Burckart
United States Food and Drug Administration(US)Center for Drug Evaluation and Research(US)
Publications by Year
Research Areas
Renal Transplantation Outcomes and Treatments, Pharmacological Effects and Toxicity Studies, Metabolism and Genetic Disorders, Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications(2008)162 cited
- → Effect of bile on cyclosporin absorption in liver transplant patients.(1988)104 cited
- → IMPDH1 Gene Polymorphisms and Association With Acute Rejection in Renal Transplant Patients(2007)99 cited
- → Failed Pediatric Drug Development Trials(2015)94 cited
- → Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary(2017)94 cited
- Biopharmaceutical aspects of FK-506.(1987)
- Excretion of cyclosporine and its metabolites in human bile.(1986)
- → A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development(2015)33 cited
- → The kinetics of cyclosporine and its metabolites in bone marrow transplant patients.(1991)30 cited
- → Pharmacogenomic information in FDA‐approved drug labels: Application to pediatric patients(2015)25 cited